Objective:Observe the clinical efficacy and safety of Tongyang Lishi decoction on cervical spondylotic radiculopathy. Method:Divided 120 patients with acute phase of cervical spondylotic radiculopathy into control group(60 cases off 3 cases) and treatment group(60 cases off 2 cases).Method at control group

gave a 20% intravenous mannitol for 5 days

then changed to give a 20% glycerol and fructose injection for 5 days;methods at treatment group

followed by oral Tongyang Lishi decoction to complete 10 days of treatment. Used 35 points integration formula to evaluate the efficacy and safety of cervical spondylotic radiculopathy. Result:Both two groups have significantly effect in improving the clinical symptoms(P<0.05)

no statistically significant occurs for two groups(P>0.05).Control group has high incidence of thrombophlebitis

while treatment group has no obvious adverse reactions. Conclusion:Tongyang Lishi decoction could improve the clinical symptoms and signs of cervical spondylotic radiculopathy patients effectively

there was no significant vascular injury

and it is worth popularizing in clinical practice for its convenient use.